Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 622,840
  • Shares Outstanding, K 64,677
  • Annual Sales, $ 0 K
  • Annual Income, $ -90,210 K
  • 60-Month Beta -0.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.88
Trade TERN with:

Options Overview Details

View History
  • Implied Volatility 116.97% ( -0.64%)
  • Historical Volatility 104.15%
  • IV Percentile 39%
  • IV Rank 27.28%
  • IV High 313.50% on 05/31/24
  • IV Low 43.25% on 05/21/24
  • Put/Call Vol Ratio 0.64
  • Today's Volume 4,999
  • Volume Avg (30-Day) 4,680
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 53,879
  • Open Int (30-Day) 35,421

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.33
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.37
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +21.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.98 +45.13%
on 09/04/24
11.40 -11.14%
on 09/10/24
+2.88 (+39.72%)
since 08/16/24
3-Month
6.38 +58.78%
on 06/26/24
11.40 -11.14%
on 09/10/24
+2.76 (+37.45%)
since 06/18/24
52-Week
3.26 +210.74%
on 11/10/23
11.40 -11.14%
on 09/10/24
+4.88 (+92.95%)
since 09/18/23

Most Recent Stories

More News
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

Terns has a modest market cap of less than $800 million, and its possible upside could be massive.

LLY : 904.97 (-0.13%)
GS : 484.58 (-0.17%)
TERN : 10.21 (+6.02%)
VKTX : 64.45 (+2.40%)
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Terns Pharmaceuticals just proved that it's competitive in the weight loss field.

VKTX : 64.45 (+2.40%)
TERN : 10.21 (+6.02%)
Should You Invest in This Under-the-Radar Weight Loss Stock?

Getting in on the ground floor sounds like a great idea, but not if the building ends up crumbling.

LLY : 904.97 (-0.13%)
TERN : 10.21 (+6.02%)
1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More

This biotech's data suggests that it could have an advantage in its target market.

TERN : 10.21 (+6.02%)
Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?

At least one of the pair has a credible shot at finding a home in the market.

LLY : 904.97 (-0.13%)
ALT : 7.43 (-1.85%)
TERN : 10.21 (+6.02%)
This Small-Cap Biotech Could Gain Over 165%, Says Wall Street

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to combat obesity. Is TERN stock a good buy right now?

TERN : 10.21 (+6.02%)
VKTX : 64.45 (+2.40%)
LLY : 904.97 (-0.13%)
NVO : 132.06 (+0.05%)
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 2.71 (-2.17%)
GLMD : 6.90 (-54.30%)
VKTX : 64.45 (+2.40%)
ETNB : 8.31 (-0.48%)
IVA : 2.19 (+0.46%)
SGMT : 3.38 (unch)
TERN : 10.21 (+6.02%)
NVO : 132.06 (+0.05%)
IQV : 242.67 (+1.12%)
MDGL : 233.16 (-0.09%)
3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy?

NASH treatments are projected to be one of the most sought-after indications in the coming years.

MDGL : 233.16 (-0.09%)
TERN : 10.21 (+6.02%)
VKTX : 64.45 (+2.40%)
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It

NASH is a surprisingly common ailment, and the first treatments are on the way.

GILD : 83.89 (+1.01%)
NVO : 132.06 (+0.05%)
LLY : 904.97 (-0.13%)
TERN : 10.21 (+6.02%)
VKTX : 64.45 (+2.40%)
MDGL : 233.16 (-0.09%)
Why Shares of Terns Pharmaceuticals Soared This Week

The company is showing progress toward a NASH therapy.

NVS : 115.97 (+0.23%)
TERN : 10.21 (+6.02%)

Business Summary

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY,...

See More

Key Turning Points

3rd Resistance Point 10.89
2nd Resistance Point 10.55
1st Resistance Point 10.09
Last Price 10.21
1st Support Level 9.28
2nd Support Level 8.94
3rd Support Level 8.48

See More

52-Week High 11.40
Last Price 10.21
Fibonacci 61.8% 8.29
Fibonacci 50% 7.33
Fibonacci 38.2% 6.37
52-Week Low 3.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar